» Articles » PMID: 18457676

Role of Calnexin in the ER Quality Control and Productive Folding of CFTR; Differential Effect of Calnexin Knockout on Wild-type and DeltaF508 CFTR

Overview
Specialties Biochemistry
Biophysics
Date 2008 May 7
PMID 18457676
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis (CF) is caused by the mutation in CF transmembrane conductance regulator (CFTR), a cAMP-dependent Cl(-) channel at the plasma membrane of epithelium. The most common mutant, DeltaF508 CFTR, has competent Cl(-) channel function, but fails to express at the plasma membrane since it is retained in the endoplasmic reticulum (ER) by the ER quality control system. Here, we show that calnexin (CNX) is not necessary for the ER retention of DeltaF508 CFTR. Our data show that CNX knockout (KO) does not affect the biosynthetic processing, cellular localization or the Cl(-) channel function of DeltaF508 CFTR. Importantly, cAMP-induced Cl(-) current in colonic epithelium from CNX KO/DeltaF508 CFTR mice was comparable with that of DeltaF508 CFTR mice, indicating that CNX KO failed to rescue the ER retention of DeltaF508 CFTR in vivo. Moreover, we show that CNX assures the efficient expression of WT CFTR, but not DeltaF508 CFTR, by inhibiting the proteasomal degradation, indicating that CNX might stimulate the productive folding of WT CFTR, but not DeltaF508 CFTR, which has folding defects.

Citing Articles

Proteostasis Landscapes of Cystic Fibrosis Variants Reveals Drug Response Vulnerability.

McDonald E, Kim M, Olson 3rd J, Olson J, Meiler J, Plate L bioRxiv. 2024; .

PMID: 39026768 PMC: 11257600. DOI: 10.1101/2024.07.10.602964.


CFTR Folding: From Structure and Proteostasis to Cystic Fibrosis Personalized Medicine.

McDonald E, Meiler J, Plate L ACS Chem Biol. 2023; 18(10):2128-2143.

PMID: 37730207 PMC: 10595991. DOI: 10.1021/acschembio.3c00310.


Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Strub M, McCray Jr P Genes (Basel). 2020; 11(5).

PMID: 32414011 PMC: 7288469. DOI: 10.3390/genes11050546.


Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis.

Fukuda R, Okiyoneda T Pharmaceuticals (Basel). 2020; 13(4).

PMID: 32331485 PMC: 7243099. DOI: 10.3390/ph13040075.


Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.

Estabrooks S, Brodsky J Int J Mol Sci. 2020; 21(2).

PMID: 31936842 PMC: 7013518. DOI: 10.3390/ijms21020452.